Evidence map›Paper›PMID 28646493›Full record

ArticleCytoskeleton (Hoboken, N.J.)2017

Src family kinase phosphorylation of the motor domain of the human kinesin-5, Eg5.

Kathleen G Bickel, Barbara J Mann, Joshua S Waitzman, Taylor A Poor, Sarah E Rice, Patricia Wadsworth

Open access · greenAbstract read
In one paragraph

Article in Cytoskeleton (Hoboken, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Kinesin Spindle Protein (KIF11) in Mitosis and Cancer.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Inhibitions and Down-Regulation of Motor Protein Eg5 Expression in Primary Sensory Neurons Reveal a Novel Therapeutic Target for Pathological Pain.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Article
  11. Article
  12. KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment.Computational and mathematical methods in medicine · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Phospho-regulation of mitotic spindle assembly.Cytoskeleton (Hoboken, N.J.) · 2020
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kathleen G BickelDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, 60611.
Barbara J MannDepartment of Biology, University of Massachusetts, Amherst, Massachusetts, 01003.
Joshua S WaitzmanDepartment of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, 60611.
Taylor A PoorDepartment of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, 60611.
Sarah E RiceDepartment of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, 60611.
Patricia WadsworthDepartment of Biology, University of Massachusetts, Amherst, Massachusetts, 01003.
Northwestern University · USUniversity of Massachusetts Amherst · US

Funding

Src kinase phosphoregulation of the human mitotic kinesin, Eg5R01GM107209 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RICE, SARAH E. · 2013 to 2016
$1.4M
NIGMS NIH HHS R01 GM107209
6 · The paper itself

Abstract

Spindle formation in mammalian cells requires precise spatial and temporal regulation of the kinesin-5, Eg5, which generates outward force to establish spindle bipolarity. Our results demonstrate that Eg5 is phosphorylated in cultured cells by Src family kinases (SFKs) at three sites in the motor head: Y125, Y211, and Y231. Mutation of these sites diminishes motor activity in vitro, and replacement of endogenous Eg5 with phosphomimetic Y211 in LLC-Pk1 cells results in monopolar spindles, consistent with loss of Eg5 activity. Cells treated with SFK inhibitors show defects in spindle formation, similar to those in cells expressing the nonphosphorylatable Y211 mutant, and distinct from inhibition of other mitotic kinases. We propose that this phosphoregulatory mechanism tunes Eg5 enzymatic activity for optimal spindle morphology.

Indexed as

Mutation, MissenseAmino Acid SubstitutionHumansKinesinsPhosphorylationSpindle Apparatussrc-Family KinasesKIF11 protein, humanKinesinssrc-Family KinasesEg5kinesinmitosismotor domainphosphorylationspindleSrc kinases

Identifiers

PMID28646493
PMCPMC5735839
OpenAlexW2688095833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.